From Resection to Disconnection for Seizure Control in Pediatric Epilepsy Children

Jun Kyu Hwang1, Dong-Seok Kim1

  • 1Department of Pediatric Neurosurgery, Severance Children's Hospital, Yonsei University College of Medicine, Seoul, Korea.

Insights

Disconnection surgery, like functional hemispherotomy, offers improved seizure control for pediatric epilepsy. This approach isolates affected brain areas, minimizing complications associated with resective surgery.

Area of Science:

  • Neurosurgery
  • Pediatric Neurology
  • Epileptology

Background:

  • Epilepsy surgery significantly improves outcomes in drug-resistant epilepsy compared to medical management.
  • Pediatric epilepsy often involves multiple foci, necessitating multilobar resections with associated risks like hydrocephalus.
  • Disconnection surgery, an alternative to resective surgery, aims to control seizures by isolating affected brain regions.

Purpose of the Study:

  • To review recent advancements in disconnection surgeries for refractory pediatric epilepsy.
  • To discuss indications, surgical techniques, seizure outcomes, and complications of these procedures.
  • To highlight the efficacy of functional hemispherotomy and similar isolation methods.

Main Methods:

  • Review of current literature on disconnection surgeries for pediatric epilepsy.
  • Analysis of surgical techniques, including functional hemispherotomy.
  • Evaluation of seizure outcomes and complication rates.

Main Results:

  • Disconnection surgeries, particularly functional hemispherotomy, demonstrate excellent seizure control in pediatric epilepsy.
  • These methods allow for functional isolation of affected hemispheres or lobes, preserving healthy brain tissue.
  • Refined techniques are continually improving the safety and efficacy of these procedures.

Conclusions:

  • Disconnection surgery is a valuable alternative to multilobar resection for pediatric epilepsy.
  • Functional hemispherotomy and related techniques offer significant seizure reduction with manageable complications.
  • Continued refinement of disconnection strategies holds promise for managing refractory pediatric epilepsy.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.2K
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.4K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
276
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
200
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
265